Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?

por Denkinger, Claudia M., Pai, Madhukar, Dowdy, David W.
Publicado 2014

Addressing critical needs in the fight to end tuberculosis with innovative tools and strategies

por Hatherill, Mark, Chaisson, Richard E., Denkinger, Claudia M.
Publicado 2019

Modeling the impact of novel diagnostic tests on pediatric and extrapulmonary tuberculosis

por Denkinger, Claudia M, Kampmann, Beate, Ahmed, Syed, Dowdy, David W
Publicado 2014

New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF

por Ponnudurai, Nirros, Denkinger, Claudia M., Van Gemert, Wayne, Pai, Madhukar
Publicado 2018

Prediction of local COVID-19 spread in Heidelberg

por Koeppel, Lisa, Gottschalk, Claudius, Welker, Andreas, Knorr, Britta, Denkinger, Claudia M.
Publicado 2020

Differential yield of universal versus selective drug susceptibility testing of patients with tuberculosis in high-burden countries: a systematic review and meta-analysis

por Svadzian, Anita, Sulis, Giorgia, Gore, Genevieve, Pai, Madhukar, Denkinger, Claudia M
Publicado 2020

Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence

por Lange, Christoph, Mandalakas, Anna M., Kalsdorf, Barbara, Denkinger, Claudia M., Sester, Martina
Publicado 2017

Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study

por Kendall, Emily A., Schumacher, Samuel G., Denkinger, Claudia M., Dowdy, David W.
Publicado 2017

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifam...

por Howlett, Patrick, Nabeta, Pamela, Tukvadze, Nestan, Schumacher, Samuel G., Denkinger, Claudia M.
Publicado 2021

Toward the Development of a Circulating Free DNA-Based In Vitro Diagnostic Test for Infectious Diseases: a Review of Evidence for Tuberculosis

por Fernández-Carballo, B. Leticia, Broger, Tobias, Wyss, Romain, Banaei, Niaz, Denkinger, Claudia M.
Publicado 2019

The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis

por Ricks, Saskia, Denkinger, Claudia M., Schumacher, Samuel G., Hallett, Timothy B., Arinaminpathy, Nimalan
Publicado 2020

Experiences with opt-in, at-home screening for SARS-CoV-2 at a primary school in Germany: an implementation study

por Wachinger, Jonas, Schirmer, Maximilian, Täuber, Nicole, McMahon, Shannon A, Denkinger, Claudia M
Publicado 2021

Validating novel diagnostic assays for tuberculosis in the context of existing tools

por Kerkhoff, Andrew D, Cattamanchi, Adithya, Muyoyeta, Monde, Denkinger, Claudia M, Dowdy, David W
Publicado 2021

Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations

por Kendall, Emily A., Malhotra, Shelly, Cook-Scalise, Sarah, Denkinger, Claudia M., Dowdy, David W.
Publicado 2019

Performance of Saliva, Oropharyngeal Swabs, and Nasal Swabs for SARS-CoV-2 Molecular Detection: a Systematic Review and Meta-analysis

por Lee, Rose A., Herigon, Joshua C., Benedetti, Andrea, Pollock, Nira R., Denkinger, Claudia M.
Publicado 2021

The potential of SARS-CoV-2 antigen-detection tests in the screening of asymptomatic persons

por Wachinger, Jonas, Olaru, Ioana Diana, Horner, Susanne, Schnitzler, Paul, Heeg, Klaus, Denkinger, Claudia M.
Publicado 2021

Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests

por Denzler, Anna, Jacobs, Max L., Witte, Victoria, Schnitzler, Paul, Denkinger, Claudia M., Knop, Michael
Publicado 2022

Highly valued despite burdens: Qualitative implementation research on rapid tests for hospital-based SARS-CoV-2 screening

por Wachinger, Jonas, McMahon, Shannon A., Lohmann, Julia, De Allegri, Manuela, Denkinger, Claudia M.
Publicado 2022

Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?

por Albert, Heidi, Nathavitharana, Ruvandhi R., Isaacs, Chris, Pai, Madhukar, Denkinger, Claudia M., Boehme, Catharina C.
Publicado 2016

Scaled testing for COVID-19 needs community involvement

por Adams, Emily R, Wolday, Dawit, Denkinger, Claudia M, Krishna, Sanjeev, de Wit, Tobias F Rinke
Publicado 2021